価格表

在庫・価格 : 2024年05月18日 08時59分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Survivin, Human, Rabbit-Poly
データシート※最新のデータシートでない場合があります
AF886 RSDアールアンドディー システムス
R&D Systems, Inc.
100 μg ¥87,000
(未発注)
追加

在庫・価格 : 2024年05月18日 08時59分 現在

Anti-Survivin, Human, Rabbit-Poly

  • 商品コード:AF886
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥87,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Zhao J et al. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell. Sci. 2000 Dec;113 Pt 23:4363-71
Zhao J et al
2000/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
2 Fukuda S et al. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 2002 Oct;100(7):2463-71
Fukuda S et al
2002/01/01
Application: Flow Cytometry PubMed
3 Aoki Y et al. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 2003 Feb;101(4):1535-42
Aoki Y et al
2003/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
4 Temme A et al. Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell. Mol. Biol. Cell 2003 Jan;14(1):78-92
Temme A et al
2003/01/01
Species: Human, Application: IHC Fresh, Sample type: Whole Cells PubMed
5 Kappler M et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin. Cancer Res. 2003 Mar;9(3):1098-104
Kappler M et al
2003/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
6 Medici MA et al. Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB. J. Biol. Chem. 2003 Sep;278(38):36059-67
Medici MA et al
2003/01/01
Application: Western Blot PubMed
7 Fulda S et al. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 2004 Jan;64(1):337-46
Fulda S et al
2004/01/01
Application: Flow Cytometry,Western Blot, Sample Type: Whole Cells PubMed
8 Wiesenauer CA et al. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J. Am. Coll. Surg. 2004 Mar;198(3):410-21
Wiesenauer CA et al
2004/01/01
Application: Western Blot PubMed
9 Lu B et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res. 2004 Apr;64(8):2840-5
Lu B et al
2004/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
10 Li CQ et al. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May;64(9):3022-9
Li CQ et al
2004/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
11 Altznauer F et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 2004 May;199(10):1343-54
Altznauer F et al
2004/01/01
Application: Western Blot, Sample Type: Whole Cells PubMed
12 Tamm I et al. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin. Cancer Res. 2004 Jun;10(11):3737-44
Tamm I et al
2004/01/01
Application: Western Blot PubMed
13 Shankar SL et al. UCN-01 alters phosphorylation of Akt and GSK3beta and induces apoptosis in six independent human neuroblastoma cell lines. J. Neurochem. 2004 Aug;90(3):702-11
Shankar SL et al
2004/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
14 Sampath SC et al. The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly. Cell 2004 Jul;118(2):187-202
Sampath SC et al
2004/01/01
Application: IHC Fresh/Frozen,Western Blot, Sample Type: Cell Lysates,Whole Cells PubMed
15 Fukuda S et al. Activated H-Ras regulates hematopoietic cell survival by modulating Survivin. Biochem. Biophys. Res. Commun. 2004 Oct;323(2):636-44
Fukuda S et al
2004/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
16 McNeish IA et al. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis. Exp. Cell Res. 2005 Jan;302(1):69-82
McNeish IA et al
2005/01/01
Application: Affinity Chromatography,Western Blot, Sample Type: Cell Lysates PubMed
17 Schaft N et al. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. J. Immunol. 2005 Mar;174(5):3087-97
Schaft N et al
2005/01/01
Application: Flow Cytometry, Sample Type: Whole Cells PubMed
18 Fulda S et al. Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling. Eur. J. Cancer 2005 Mar;41(5):786-98
Fulda S et al
2005/01/01
Application: Western Blot, Sample Type: Whole Cells PubMed
19 Gurbuxani S et al. Differential requirements for survivin in hematopoietic cell development. Proc. Natl. Acad. Sci. U.S.A. 2005 Aug;102(32):11480-5
Gurbuxani S et al
2005/01/01
Application: Flow Cytometry,Western Blot, Sample Type: Cell Lysates,Whole Cells PubMed
20 Yonesaka K et al. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. Int. J. Cancer 2006 Feb;118(4):812-20
Yonesaka K et al
2006/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
21 Wang Z et al. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis. Cancer Res. 2005 Sep;65(18):8224-32
Wang Z et al
2005/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
22 Thangaraju M et al. C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 2005 Nov;132(21):4675-85
Thangaraju M et al
2005/01/01
Application: Western Blot, Sample Type: Homogenized Tissue - Protocol Included PubMed
23 Carter BZ et al. Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells. Blood 2006 Feb;107(4):1555-63
Carter BZ et al
2006/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
24 Giagkousiklidis S et al. Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. Cancer Res. 2005 Nov;65(22):10502-13
Giagkousiklidis S et al
2005/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
25 Lens SM et al. Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. Mol. Biol. Cell 2006 Apr;17(4):1897-909
Lens SM et al
2006/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
26 Fulda S et al. 5-Aza-2"-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 2006 Aug;25(37):5125-33
Fulda S et al
2006/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
27 Wagner M et al. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia. Int. J. Cancer 2006 Sep;119(6):1291-7
Wagner M et al
2006/01/01
Species: Human, Application: Western Blot, Cell Lysates PubMed
28 Vassina EM et al. cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis. Eur. J. Immunol. 2006 Jul;36(7):1975-84
Vassina EM et al
2006/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
29 Perabo FG et al. Indirubin-3"-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer. Anticancer Res. ;26(3A):2129-35
Perabo FG et al
Application: Western Blot, Sample Type: Cell Lysates PubMed
30 Botchkareva NV et al. Survivin in the human hair follicle. J. Invest. Dermatol. 2007 Feb;127(2):479-82
Botchkareva NV et al
2007/01/01
Application: IHC Fresh/Frozen, Sample Type: Whole Tissue PubMed
31 Kulp SK et al. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer. Clin. Cancer Res. 2006 Sep;12(17):5199-206
Kulp SK et al
2006/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
32 Kilic M et al. Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene 2007 Mar;26(14):2027-38
Kilic M et al
2007/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
33 Temme A et al. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Cancer Lett. 2007 Jun;250(2):177-93
Temme A et al
2007/01/01
Species: Human, Application: IHC Fresh, Sample type: Whole Cells PubMed
34 Kleinberg L et al. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma. Cancer 2007 Jan;109(2):228-38
Kleinberg L et al
2007/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
35 Coughlin CM et al. Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma. J. Clin. Oncol. 2006 Dec;24(36):5725-34
Coughlin CM et al
2006/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
36 Gordon GJ et al. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma. J. Pathol. 2007 Mar;211(4):439-46
Gordon GJ et al
2007/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
37 Sakoguchi-Okada N et al. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells. Biochem. Pharmacol. 2007 May;73(9):1318-29
Sakoguchi-Okada N et al
2007/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
38 Lopes RB et al. Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int. J. Cancer 2007 Jun;120(11):2344-52
Lopes RB et al
2007/01/01
Species: Human, Application: IHC Frozen, IHC Paraffin-embedded, Sample type: Whole Tissue PubMed
39 Elojeimy S et al. Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy. Mol. Ther. 2007 Jul;15(7):1259-63
Elojeimy S et al
2007/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
40 Lippa MS et al. Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Apoptosis 2007 Aug;12(8):1465-78
Lippa MS et al
2007/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
41 Giagkousiklidis S et al. Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition. Oncogene 2007 Oct;26(49):7006-16
Giagkousiklidis S et al
2007/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
42 Vader G et al. The chromosomal passenger complex controls spindle checkpoint function independent from its role in correcting microtubule kinetochore interactions. Mol. Biol. Cell 2007 Nov;18(11):4553-64
Vader G et al
2007/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
43 Hu H et al. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin. J. Leukoc. Biol. 2008 Feb;83(2):393-400
Hu H et al
2008/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
44 Lechler P et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am. J. Pathol. 2007 Nov;171(5):1483-98
Lechler P et al
2007/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
45 Ushmorov A et al. N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells. Oncogene 2008 May;27(24):3424-34
Ushmorov A et al
2008/01/01
Species: Human, Application: Western Blot, Whole Cells PubMed
46 Goda AE et al. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole. Oncogene 2008 May;27(24):3435-45
Goda AE et al
2008/01/01
Species: Human, Application: Western Blot, Cell Lysates PubMed
47 Hu CK et al. Cell polarization during monopolar cytokinesis. J. Cell Biol. 2008 Apr;181(2):195-202
Hu CK et al
2008/01/01
Species: Human, Application: IHC, Whole Cells PubMed
48 Rou辿 G et al. Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators. Oncogene 2008 Aug;27(36):4909-20
Rou辿 G et al
2008/01/01
Species: Mouse, Application: Western Blot, Cell Lysates PubMed
49 Gaiser T et al. TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin. Neurosci. Lett. 2008 Sep;442(2):109-13
Gaiser T et al
2008/01/01
Species: Human, Application: Western Blot, Cell Lysates PubMed
50 Schile AJ et al. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 2008 Aug;22(16):2256-66
Schile AJ et al
2008/01/01
Species: Mouse, Application: Western Blot, Cell Lysates PubMed
51 Wang WL et al. Effects of Iejimalide B, a marine macrolide, on growth and apoptosis in prostate cancer cell lines. J. Cell. Biochem. 2008 Nov;105(4):998-1007
Wang WL et al
2008/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
52 Zhang Y et al. SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett. 2009 May;277(1):29-37
Zhang Y et al
2009/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
53 Siegelin MD et al. KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway. Neurobiol. Dis. 2009 May;34(2):259-66
Siegelin MD et al
2009/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
54 Siegelin MD et al. Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2. Cancer Lett. 2009 Oct;283(2):230-8
Siegelin MD et al
2009/01/01
Application: Western Blot, Sample Type: whole cell PubMed
55 Siegelin MD et al. Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2. Neurosci. Lett. 2009 May;454(3):223-8
Siegelin MD et al
2009/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
56 Lin J et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin. Cancer Res. 2010 Jan;16(1):77-87
Lin J et al
2010/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
57 Kojima K et al. Mitogen-activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells. Cancer Res. 2007 Apr;67(7):3210-9
Kojima K et al
2007/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
58 L旦der S et al. RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis. Leukemia 2012 May;26(5):1020-9
L旦der S et al
2012/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
59 Enges脱ter B et al. Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma. PLoS ONE 2012;7(9):e45492
Enges脱ter B et al
2012/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
60 Toosi S et al. Serum levels of inhibitors of apoptotic proteins (IAPs) change with IVIg therapy in pemphigus. J. Invest. Dermatol. 2011 Nov;131(11):2327-9
Toosi S et al
2011/01/01
Application: Western Blot, Sample Type: Serum PubMed
61 Wagner L et al. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner. Oncogene 2013 Feb;32(8):988-97
Wagner L et al
2013/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
62 Mu単oz-Repeto I et al. Phenotypic characterization of hereditary epithelial ovarian cancer based on a tissue microarray study. Histol. Histopathol. 2013 Jan;28(1):133-44
Mu単oz-Repeto I et al
2013/01/01
Application: IHC Paraffin-embedded, Sample Type: whole cells PubMed
63 Hage C et al. The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Cell Death Dis 2013;4:e627
Hage C et al
2013/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
64 Gupta SC et al. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of th
Gupta SC et al
2013/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
65 Weber T et al. Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma. Onco Targets Ther 2014;7:645-54
Weber T et al
2014/01/01
Application: IHC, Sample Type: tissue PubMed
66 Wiedemuth R et al. Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53. Mol. Cancer 2014;13:107
Wiedemuth R et al
2014/01/01
Application: Western Blot, Sample Type: Cell Lysate PubMed
67 Umemori Y et al. Protein kinase C ζ regulates survivin expression and inhibits apoptosis in colon cancer. Int. J. Oncol. 2014 Sep;45(3):1043-50
Umemori Y et al
2014/01/01
Application: Western Blot, Sample Type: Total protein PubMed
68 Qin Q et al. Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair. J Hematol Oncol 2014;7:62
Qin Q et al
2014/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
69 Nestal de Moraes G et al. The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors. Int. J. Oncol. 2014 Nov;45(5):1949-58
Nestal de Moraes G et al
2014/01/01
Application: Western Blot, Sample Type: Total protein PubMed
70 Sarveswaran S et al. MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic pro
Sarveswaran S et al
2015/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
71 Wang H et al. Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms. J Hematol Oncol 2015;8:26
Wang H et al
2015/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
72 Ghosh SK et al. Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma. Int. J. Cancer 2014 Apr;134(7):1758-66
Ghosh SK et al
2014/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
73 Gallouet AS et al. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis. Clin. Cancer Res. 2014 May;20(10):2663-73
Gallouet AS et al
2014/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
74 Fern叩ndez JG et al. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription. Mol. Cancer 2014;13:209
Fern叩ndez JG et al
2014/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
75 Ram鱈rez de Arellano A et al. STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells. Cancer Cell Int. 2015;15:83
Ram鱈rez de Arellano A et al
2015/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
76 Li X et al. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors. BMC Cancer 2015;15:974
Li X et al
2015/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
77 Lin KY et al. Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study. Onco Targets Ther 2016;9:2601-13
Lin KY et al
2016/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
78 Engel K et al. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma. EMBO Mol Med 2016 Aug;8(8):851-62
Engel K et al
2016/01/01
Application: Western Blot, Sample Type: Whole Cells PubMed
79 Mト囘ra A et al. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies. Molecules 2016 Jul;21(8)
Mト囘ra A et al
2016/01/01
Application: Flow Cytometry, Sample Type: Whole Cells PubMed
80 Reich TR et al. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome. Oncotarget 2017 Feb;8(9):15071-15084
Reich TR et al
2017/01/01
Application: Western Blot, Sample Type: cell lysaets PubMed
81 Fitzpatrick C et al. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors. Cell Death Dis 2019 May;10(6):423
Fitzpatrick C et al
2019/01/01
PubMed
82 Tsai SL et al. Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli. Protein Expr. Purif. 2019 Aug;160:73-83
Tsai SL et al
2019/01/01
PubMed
83 Hehlgans S et al. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib. Int J Mol Sci 2018 Aug;19(9)
Hehlgans S et al
2018/01/01
PubMed
84 Conde M et al. Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells. BMC Cancer 2017 12;17(1):889
Conde M et al
2017/01/01
PubMed
85 Jiang X et al. Disruption of Wnt/&#x3B2;-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i>-Mutant Acute Myeloid Leukemia. Clin Cancer Res 2018 05;24(10):2417-2429
Jiang X et al
2018/01/01
PubMed
86 Lin TY et al. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy 2020 Jul;16(7):1296-1313
Lin TY et al
2020/01/01
PubMed
87 Garrido MP et al. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE<sub>2</sub> Signaling Axis. Cancers (Basel) 2019 Dec;11(12)
Garrido MP et al
2019/01/01
PubMed
88 Nishisaka F et al. Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701. Cancer Sci 2020 May;111(5):1774-1784
Nishisaka F et al
2020/01/01
PubMed
89 Jugel W et al. Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors. Pharmaceutics 2021 May;13(5)
Jugel W et al
2021/01/01
Species: Human, Applications: Western Blot PubMed
90 Rodrigues Moita AJ et al. Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. Int J Mol Sci 2020 Nov;21(21)
Rodrigues Moita AJ et al
2020/01/01
Species: Human, Applications: Western Blot PubMed
  • No.: 1
  • 文献情報:
    Zhao J et al. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell. Sci. 2000 Dec;113 Pt 23:4363-71
    Zhao J et al
    2000/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Fukuda S et al. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 2002 Oct;100(7):2463-71
    Fukuda S et al
    2002/01/01
  • 備考:
    Application: Flow Cytometry
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Aoki Y et al. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 2003 Feb;101(4):1535-42
    Aoki Y et al
    2003/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Temme A et al. Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell. Mol. Biol. Cell 2003 Jan;14(1):78-92
    Temme A et al
    2003/01/01
  • 備考:
    Species: Human, Application: IHC Fresh, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kappler M et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin. Cancer Res. 2003 Mar;9(3):1098-104
    Kappler M et al
    2003/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Medici MA et al. Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB. J. Biol. Chem. 2003 Sep;278(38):36059-67
    Medici MA et al
    2003/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Fulda S et al. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 2004 Jan;64(1):337-46
    Fulda S et al
    2004/01/01
  • 備考:
    Application: Flow Cytometry,Western Blot, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wiesenauer CA et al. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J. Am. Coll. Surg. 2004 Mar;198(3):410-21
    Wiesenauer CA et al
    2004/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Lu B et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res. 2004 Apr;64(8):2840-5
    Lu B et al
    2004/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Li CQ et al. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May;64(9):3022-9
    Li CQ et al
    2004/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Altznauer F et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 2004 May;199(10):1343-54
    Altznauer F et al
    2004/01/01
  • 備考:
    Application: Western Blot, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Tamm I et al. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin. Cancer Res. 2004 Jun;10(11):3737-44
    Tamm I et al
    2004/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Shankar SL et al. UCN-01 alters phosphorylation of Akt and GSK3beta and induces apoptosis in six independent human neuroblastoma cell lines. J. Neurochem. 2004 Aug;90(3):702-11
    Shankar SL et al
    2004/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Sampath SC et al. The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly. Cell 2004 Jul;118(2):187-202
    Sampath SC et al
    2004/01/01
  • 備考:
    Application: IHC Fresh/Frozen,Western Blot, Sample Type: Cell Lysates,Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Fukuda S et al. Activated H-Ras regulates hematopoietic cell survival by modulating Survivin. Biochem. Biophys. Res. Commun. 2004 Oct;323(2):636-44
    Fukuda S et al
    2004/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    McNeish IA et al. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis. Exp. Cell Res. 2005 Jan;302(1):69-82
    McNeish IA et al
    2005/01/01
  • 備考:
    Application: Affinity Chromatography,Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Schaft N et al. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. J. Immunol. 2005 Mar;174(5):3087-97
    Schaft N et al
    2005/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Fulda S et al. Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling. Eur. J. Cancer 2005 Mar;41(5):786-98
    Fulda S et al
    2005/01/01
  • 備考:
    Application: Western Blot, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Gurbuxani S et al. Differential requirements for survivin in hematopoietic cell development. Proc. Natl. Acad. Sci. U.S.A. 2005 Aug;102(32):11480-5
    Gurbuxani S et al
    2005/01/01
  • 備考:
    Application: Flow Cytometry,Western Blot, Sample Type: Cell Lysates,Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Yonesaka K et al. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. Int. J. Cancer 2006 Feb;118(4):812-20
    Yonesaka K et al
    2006/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Wang Z et al. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis. Cancer Res. 2005 Sep;65(18):8224-32
    Wang Z et al
    2005/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Thangaraju M et al. C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 2005 Nov;132(21):4675-85
    Thangaraju M et al
    2005/01/01
  • 備考:
    Application: Western Blot, Sample Type: Homogenized Tissue - Protocol Included
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Carter BZ et al. Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells. Blood 2006 Feb;107(4):1555-63
    Carter BZ et al
    2006/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Giagkousiklidis S et al. Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. Cancer Res. 2005 Nov;65(22):10502-13
    Giagkousiklidis S et al
    2005/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Lens SM et al. Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. Mol. Biol. Cell 2006 Apr;17(4):1897-909
    Lens SM et al
    2006/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Fulda S et al. 5-Aza-2&quot;-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 2006 Aug;25(37):5125-33
    Fulda S et al
    2006/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Wagner M et al. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia. Int. J. Cancer 2006 Sep;119(6):1291-7
    Wagner M et al
    2006/01/01
  • 備考:
    Species: Human, Application: Western Blot, Cell Lysates
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Vassina EM et al. cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis. Eur. J. Immunol. 2006 Jul;36(7):1975-84
    Vassina EM et al
    2006/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Perabo FG et al. Indirubin-3&quot;-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer. Anticancer Res. ;26(3A):2129-35
    Perabo FG et al
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Botchkareva NV et al. Survivin in the human hair follicle. J. Invest. Dermatol. 2007 Feb;127(2):479-82
    Botchkareva NV et al
    2007/01/01
  • 備考:
    Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Kulp SK et al. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer. Clin. Cancer Res. 2006 Sep;12(17):5199-206
    Kulp SK et al
    2006/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Kilic M et al. Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene 2007 Mar;26(14):2027-38
    Kilic M et al
    2007/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Temme A et al. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Cancer Lett. 2007 Jun;250(2):177-93
    Temme A et al
    2007/01/01
  • 備考:
    Species: Human, Application: IHC Fresh, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Kleinberg L et al. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma. Cancer 2007 Jan;109(2):228-38
    Kleinberg L et al
    2007/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Coughlin CM et al. Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma. J. Clin. Oncol. 2006 Dec;24(36):5725-34
    Coughlin CM et al
    2006/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Gordon GJ et al. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma. J. Pathol. 2007 Mar;211(4):439-46
    Gordon GJ et al
    2007/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Sakoguchi-Okada N et al. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells. Biochem. Pharmacol. 2007 May;73(9):1318-29
    Sakoguchi-Okada N et al
    2007/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Lopes RB et al. Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int. J. Cancer 2007 Jun;120(11):2344-52
    Lopes RB et al
    2007/01/01
  • 備考:
    Species: Human, Application: IHC Frozen, IHC Paraffin-embedded, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Elojeimy S et al. Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy. Mol. Ther. 2007 Jul;15(7):1259-63
    Elojeimy S et al
    2007/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Lippa MS et al. Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Apoptosis 2007 Aug;12(8):1465-78
    Lippa MS et al
    2007/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Giagkousiklidis S et al. Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition. Oncogene 2007 Oct;26(49):7006-16
    Giagkousiklidis S et al
    2007/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Vader G et al. The chromosomal passenger complex controls spindle checkpoint function independent from its role in correcting microtubule kinetochore interactions. Mol. Biol. Cell 2007 Nov;18(11):4553-64
    Vader G et al
    2007/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Hu H et al. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin. J. Leukoc. Biol. 2008 Feb;83(2):393-400
    Hu H et al
    2008/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Lechler P et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am. J. Pathol. 2007 Nov;171(5):1483-98
    Lechler P et al
    2007/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Ushmorov A et al. N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells. Oncogene 2008 May;27(24):3424-34
    Ushmorov A et al
    2008/01/01
  • 備考:
    Species: Human, Application: Western Blot, Whole Cells
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Goda AE et al. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole. Oncogene 2008 May;27(24):3435-45
    Goda AE et al
    2008/01/01
  • 備考:
    Species: Human, Application: Western Blot, Cell Lysates
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Hu CK et al. Cell polarization during monopolar cytokinesis. J. Cell Biol. 2008 Apr;181(2):195-202
    Hu CK et al
    2008/01/01
  • 備考:
    Species: Human, Application: IHC, Whole Cells
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Rou辿 G et al. Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators. Oncogene 2008 Aug;27(36):4909-20
    Rou辿 G et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Western Blot, Cell Lysates
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Gaiser T et al. TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin. Neurosci. Lett. 2008 Sep;442(2):109-13
    Gaiser T et al
    2008/01/01
  • 備考:
    Species: Human, Application: Western Blot, Cell Lysates
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Schile AJ et al. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 2008 Aug;22(16):2256-66
    Schile AJ et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Western Blot, Cell Lysates
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Wang WL et al. Effects of Iejimalide B, a marine macrolide, on growth and apoptosis in prostate cancer cell lines. J. Cell. Biochem. 2008 Nov;105(4):998-1007
    Wang WL et al
    2008/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Zhang Y et al. SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett. 2009 May;277(1):29-37
    Zhang Y et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Siegelin MD et al. KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway. Neurobiol. Dis. 2009 May;34(2):259-66
    Siegelin MD et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Siegelin MD et al. Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2. Cancer Lett. 2009 Oct;283(2):230-8
    Siegelin MD et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: whole cell
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Siegelin MD et al. Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2. Neurosci. Lett. 2009 May;454(3):223-8
    Siegelin MD et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Lin J et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin. Cancer Res. 2010 Jan;16(1):77-87
    Lin J et al
    2010/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Kojima K et al. Mitogen-activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells. Cancer Res. 2007 Apr;67(7):3210-9
    Kojima K et al
    2007/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    L旦der S et al. RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis. Leukemia 2012 May;26(5):1020-9
    L旦der S et al
    2012/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Enges脱ter B et al. Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma. PLoS ONE 2012;7(9):e45492
    Enges脱ter B et al
    2012/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Toosi S et al. Serum levels of inhibitors of apoptotic proteins (IAPs) change with IVIg therapy in pemphigus. J. Invest. Dermatol. 2011 Nov;131(11):2327-9
    Toosi S et al
    2011/01/01
  • 備考:
    Application: Western Blot, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Wagner L et al. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-&#x3BA;B-dependent manner. Oncogene 2013 Feb;32(8):988-97
    Wagner L et al
    2013/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Mu単oz-Repeto I et al. Phenotypic characterization of hereditary epithelial ovarian cancer based on a tissue microarray study. Histol. Histopathol. 2013 Jan;28(1):133-44
    Mu単oz-Repeto I et al
    2013/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Hage C et al. The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Cell Death Dis 2013;4:e627
    Hage C et al
    2013/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Gupta SC et al. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of th
    Gupta SC et al
    2013/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Weber T et al. Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma. Onco Targets Ther 2014;7:645-54
    Weber T et al
    2014/01/01
  • 備考:
    Application: IHC, Sample Type: tissue
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Wiedemuth R et al. Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53. Mol. Cancer 2014;13:107
    Wiedemuth R et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysate
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Umemori Y et al. Protein kinase C &#x3B6; regulates survivin expression and inhibits apoptosis in colon cancer. Int. J. Oncol. 2014 Sep;45(3):1043-50
    Umemori Y et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Total protein
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Qin Q et al. Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair. J Hematol Oncol 2014;7:62
    Qin Q et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Nestal de Moraes G et al. The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors. Int. J. Oncol. 2014 Nov;45(5):1949-58
    Nestal de Moraes G et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Total protein
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Sarveswaran S et al. MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic pro
    Sarveswaran S et al
    2015/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Wang H et al. Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms. J Hematol Oncol 2015;8:26
    Wang H et al
    2015/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Ghosh SK et al. Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma. Int. J. Cancer 2014 Apr;134(7):1758-66
    Ghosh SK et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Gallouet AS et al. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis. Clin. Cancer Res. 2014 May;20(10):2663-73
    Gallouet AS et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Fern叩ndez JG et al. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced &#x3B2;-catenin/Tcf-Lef dependent transcription. Mol. Cancer 2014;13:209
    Fern叩ndez JG et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Ram鱈rez de Arellano A et al. STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells. Cancer Cell Int. 2015;15:83
    Ram鱈rez de Arellano A et al
    2015/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Li X et al. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors. BMC Cancer 2015;15:974
    Li X et al
    2015/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Lin KY et al. Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study. Onco Targets Ther 2016;9:2601-13
    Lin KY et al
    2016/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Engel K et al. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma. EMBO Mol Med 2016 Aug;8(8):851-62
    Engel K et al
    2016/01/01
  • 備考:
    Application: Western Blot, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Mト囘ra A et al. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies. Molecules 2016 Jul;21(8)
    Mト囘ra A et al
    2016/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Reich TR et al. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome. Oncotarget 2017 Feb;8(9):15071-15084
    Reich TR et al
    2017/01/01
  • 備考:
    Application: Western Blot, Sample Type: cell lysaets
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Fitzpatrick C et al. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors. Cell Death Dis 2019 May;10(6):423
    Fitzpatrick C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Tsai SL et al. Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli. Protein Expr. Purif. 2019 Aug;160:73-83
    Tsai SL et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Hehlgans S et al. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib. Int J Mol Sci 2018 Aug;19(9)
    Hehlgans S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Conde M et al. Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells. BMC Cancer 2017 12;17(1):889
    Conde M et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Jiang X et al. Disruption of Wnt/&#x3B2;-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i>-Mutant Acute Myeloid Leukemia. Clin Cancer Res 2018 05;24(10):2417-2429
    Jiang X et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Lin TY et al. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy 2020 Jul;16(7):1296-1313
    Lin TY et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Garrido MP et al. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE<sub>2</sub> Signaling Axis. Cancers (Basel) 2019 Dec;11(12)
    Garrido MP et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Nishisaka F et al. Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701. Cancer Sci 2020 May;111(5):1774-1784
    Nishisaka F et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Jugel W et al. Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors. Pharmaceutics 2021 May;13(5)
    Jugel W et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Rodrigues Moita AJ et al. Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. Int J Mol Sci 2020 Nov;21(21)
    Rodrigues Moita AJ et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed